Avaleht › Haavandiline koliit › Illinois › Chicago
Haavandiline koliit kliinilised uuringud linnas Chicago, IL
15 uuringut haiguse Haavandiline koliit jaoks otsivad osalejaid linnas Chicago ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
VärbamineFaas 3
- University of Chicago Medical Center /ID# 271588, Chicago
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
VärbamineFaas 2
- Northwestern University, Chicago
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
VärbamineFaas 2
- Site 038, Chicago
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
VärbamineFaas 2
- University of Chicago Medical Center, Chicago
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
VärbamineFaas 3
- Rush University Medical Center, Chicago
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
VärbamineFaas 2
- Northwestern University, Chicago
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
VärbamineFaas 2
- Rush University Medical Center, Chicago
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
VärbamineFaas 2
- Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
VärbamineFaas 4
- University of Chicago Medicine, Chicago
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
VärbamineFaas 3
- Rush University Medical Center - Site Number: 8400015, Chicago
Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
Värbamine
- University of Chicago Medicine, Chicago
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
VärbamineVaatlusuuring
- Feinberg School of Medicine Northwestern University, Chicago
- Rush University Medical Center, Chicago
A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
VärbamineFaas 2
- University of Chicago Medical Center, Chicago
Selenium Supplementation in Moderate-Severely Active Ulcerative Colitis Patients Treated With Advanced Therapies
VärbamineFaas 2
- Northwestern University, Chicago
STOP-UC: De-escalation of Therapy in Patients With Ulcerative Colitis With Histological Remission
Värbamine
- University of Chicago, Chicago
Haavandiline koliit uuringud teistes linnades
- New York City, NY23 uuringut
- Orlando, FL22 uuringut
- Miami, FL21 uuringut
- Houston, TX17 uuringut
- San Antonio, TX16 uuringut
- Tacoma, WA15 uuringut
- San Diego, CA15 uuringut
- Tyler, TX14 uuringut
- Colorado Springs, CO14 uuringut
- Los Angeles, CA13 uuringut
- St. Louis, MO13 uuringut
- Washington, DC12 uuringut
Muud uuringud linnas Chicago
- Mitteväikerakuline kopsuvähk61 uuringut
- Rinnavähk58 uuringut
- Vähk (kõik liigid)51 uuringut
- Metastaatiline vähk45 uuringut
- Eesnäärmevähk45 uuringut
- Rasvumine41 uuringut
- Kopsuvähk41 uuringut
- Munasarjavähk36 uuringut
- Insult34 uuringut
- Käär- ja pärasoolevähk33 uuringut
- Südamepuudulikkus31 uuringut
- Ülekaalulisus28 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.